BAY-1895344
Catalog No: 1781002
CAS Number: 1876467-74-1
Purity: 98.0%
BAY-1895344 is developed for the treatment of patients with advanced solid tumors and lymphomas, and it is undergoing a phase I clinical trial of safety and tolerability for cancer patients.
For research use only. We do not sell to patients.
Chemical Information
| Name | BAY-1895344 |
|---|---|
| Iupac Chemical Name | (R)-3-methyl-4-(4-(1-methyl-1H-pyrazol-5-yl)-8-(1H-pyrazol-5-yl)-1,7-naphthyridin-2-yl)morpholine |
| Synonyms | BAY-1895344;BAY 1895344;BAY1895344 |
| Molecular Formula | C20H21N7O |
| Molecular Weight | 375.436 |
| Smile | C[C@H]1N(CCOC1)C1=NC2=C(N=CC=C2C(=C1)C1=CC=NN1C)C1=CC=NN1 |
| InChiKey | YBXRSCXGRPSTMW-CYBMUJFWSA-N |
| InChi | InChI=1S/C20H21N7O/c1-13-12-28-10-9-27(13)18-11-15(17-5-8-23-26(17)2)14-3-6-21-20(19(14)24-18)16-4-7-22-25-16/h3-8,11,13H,9-10,12H2,1-2H3,(H,22,25)/t13-/m1/s1 |
| CAS Number | 1876467-74-1 |
| Related CAS |
Ordering Information
| Packaging | Price | Availability | Purity | Shipping Time |
|---|---|---|---|---|
| Bulk | Enquiry | Enquiry | Enquiry |
| Formulation | off-white solid |
|---|---|
| Purity | 98.0% |
| Storage | -20 ºC for 3 years |
| Solubility | Soluble in DMSO |
| Handling | |
| Shipping Condition | Shipped under ambient temperature |
| HS Code |
Coming soon.
| Targets | |
|---|---|
| Mechanism | |
| Cell study | |
| Animal study | |
| Clinical study |
Not available
Chemical Structure
